Literature DB >> 990860

Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.

T K Chan, D Todd, S C Tso.   

Abstract

People with the variants of glucose-6-phosphate dehydrogenase (GPD) deficiency common in the southern Chinese (Canton, B(-)Chinese, and Hong Kong-Pokfulam) have a moderate shortening of red-cell survival but no anaemia when they are in the steady state. With a cross-transfusion technique, primaquine, nitrofurantoin, and large doses of aspirin were found to aggravate the haemolysis while sulphamethoxazole did so only in some people. Individual differences in drug metabolism may be the reason for this. Many commonly used drugs reported to accentuate haemolysis in GPD deficiency did not shorten red-cell survival.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990860      PMCID: PMC1689719          DOI: 10.1136/bmj.2.6046.1227

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  SURVIVAL OF 51 CR-LABELLED RED CELLS IN SUBJECTS WITH THALASSAEMIA-TRAIT OR G6PD DEFICIENCY OR BOTH ABNORMALITIES.

Authors:  L BERNINI; B LATTE; M SINISCALCO; S PIOMELLI; U SPADA; M ADINOLFI; P L MOLLISON
Journal:  Br J Haematol       Date:  1964-04       Impact factor: 6.998

2.  The hemolytic effect of primaquine and related compounds: a review.

Authors:  E BEUTLER
Journal:  Blood       Date:  1959-02       Impact factor: 22.113

3.  Haemolytic anaemia in typhoid fever; a report of six cases, together with the effect of chloramphenicol and A.C.T.H.

Authors:  A J MCFADZEAN; G H CHOA
Journal:  Br Med J       Date:  1953-08-15

4.  Haemolytic effect of trimethoprim-sulphamethoxazole in G-6-PD deficiency.

Authors:  T K Chan; J S McFadzean
Journal:  Trans R Soc Trop Med Hyg       Date:  1974       Impact factor: 2.184

5.  Red cell survival studies in haemoglobin H disease using ( 51 Cr)chromate and ( 32 P)di-isopropyl phosphofluoridate.

Authors:  S C Tso
Journal:  Br J Haematol       Date:  1972-11       Impact factor: 6.998

Review 6.  Drug-induced hemolytic anemia.

Authors:  E Beutler
Journal:  Pharmacol Rev       Date:  1969-03       Impact factor: 25.468

7.  Absence of hemolytic effects of L-DOPA on transfused G6PD-deficient erythrocytes.

Authors:  G Gaetani; E Salvidio; I Pannacciulli; F Ajmar; G Paravidino
Journal:  Experientia       Date:  1970

Review 8.  Drug-induced hemolysis.

Authors:  J Dausset; L Contu
Journal:  Annu Rev Med       Date:  1967       Impact factor: 13.739

9.  Haemolysis complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency.

Authors:  T K Chan; D Todd
Journal:  Br Med J       Date:  1975-01-18

10.  Hemolytic anemia and G6PD deficiency.

Authors:  A Yoshida
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

View more
  15 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

Review 2.  Glucose-6-phosphate dehydrogenase deficiency.

Authors:  A B Mehta
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

3.  Tolerability of tiaprofenic acid in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Authors:  Q Mela; G Perpignano; V Ruggiero; S Longatti
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 5.  Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?

Authors:  Jianle Li; Yicong Chen; Zilin Ou; Fubing Ouyang; Jiahui Liang; Zimu Jiang; Chunyong Chen; Pingping Li; Jiaxin Chen; Jiating Wei; Jinsheng Zeng
Journal:  Am J Cardiovasc Drugs       Date:  2020-12-14       Impact factor: 3.571

Review 6.  Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.

Authors:  Ilan Youngster; Lidia Arcavi; Renata Schechmaster; Yulia Akayzen; Hen Popliski; Janna Shimonov; Svetlana Beig; Matitiahu Berkovitch
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.228

Review 7.  Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy.

Authors:  Julie Gutman; S Patrick Kachur; Laurence Slutsker; Alexis Nzila; Theonest Mutabingwa
Journal:  Malar J       Date:  2012-02-09       Impact factor: 2.979

8.  Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study.

Authors:  Ruth Owusu; Kwaku Poku Asante; Emmanuel Mahama; Elizabeth Awini; Thomas Anyorigiya; David Dosoo; Alberta Amu; Gabriel Jakpa; Emmanuel Ofei; Sylvester Segbaya; Abraham Rexford Oduro; Margaret Gyapong; Abraham Hodgson; Constance Bart-Plange; Seth Owusu-Agyei
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

9.  Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.

Authors:  Arantxa Roca-Feltrer; Nimol Khim; Saorin Kim; Sophy Chy; Lydie Canier; Alexandra Kerleguer; Pety Tor; Char Meng Chuor; Sim Kheng; Sovannaroth Siv; Patrick S Kachur; Walter R J Taylor; Jimee Hwang; Didier Menard
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

10.  An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.

Authors:  Rithea Leang; Naw Htee Khu; Mavuto Mukaka; Mark Debackere; Rupam Tripura; Soy Ty Kheang; Say Chy; Neeraj Kak; Philippe Buchy; Arnaud Tarantola; Didier Menard; Arantxa Roca-Felterer; Rick M Fairhurst; Sim Kheng; Sinoun Muth; Song Ngak; Arjen M Dondorp; Nicholas J White; Walter Robert John Taylor
Journal:  BMC Med       Date:  2016-10-27       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.